Fresenius secures big buy facility
Fresenius, the German healthcare group, has mandated Credit Suisse, Deutsche Bank and JP Morgan to arrange an acquisition deal backing its $3.7bn takeover of APP Pharmaceuticals, the US drugs firm. The debt size is so far undisclosed but more details should emerge soon. Find out more in EuroWeek on Friday.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts